Patrick Aubonnet

Affiliations

Mylan EPD, Allschwil, Switzerland.

Publications (4)

Efficacy and safety of MYL-1501D versus insulin glargine in patients with type 2 diabetes after 24 weeks: Results of the phase III INSTRIDE 2 study.

Diabetes, obesity & metabolism

Avec: Thomas C Blevins , Abhijit Barve , Bin Sun , Yaron Raiter , Patrick Aubonnet , Rafael Muniz , Sandeep Athalye , Michael Ankersen

Pharmacokinetic and pharmacodynamic bioequivalence of proposed biosimilar MYL-1501D with US and European insulin glargine formulations in patients with type 1 diabetes mellitus.

Diabetes, obesity & metabolism

Avec: Tim Heise , Charles Donnelly , Abhijit Barve , Patrick Aubonnet

Efficacy and safety of MYL-1501D versus insulin glargine in people with type 1 diabetes mellitus: Results of the INSTRIDE 3 phase 3 switch study.

Diabetes, obesity & metabolism

Avec: Thomas C Blevins , Abhijit Barve , Yaron Raiter , Patrick Aubonnet , Sandeep Athalye , Bin Sun , Rafael Muniz

Similar immunogenicity profiles between the proposed biosimilar MYL-1501D and reference insulin glargine in patients with diabetes mellitus: the phase 3 INSTRIDE 1 and INSTRIDE 2 studies.

BMC endocrine disorders

Avec: Bin Sun , Nilanjan Sengupta , Anita Rao , Charles Donnelly , Vinit Waichale , Arnab Sinha Roy , Shilpa Ramaswamy , Divya Pathak , Ronald R Bowsher , Yaron Raiter , Patrick Aubonnet , Abhijit Barve

Réseau de co-auteurs

Abhijit Barve 4 collaborations

Bin Sun 3 collaborations

Yaron Raiter 3 collaborations

Thomas C Blevins 2 collaborations

Rafael Muniz 2 collaborations

Sandeep Athalye 2 collaborations

Charles Donnelly 2 collaborations

Michael Ankersen 1 collaboration

Tim Heise 1 collaboration

Nilanjan Sengupta 1 collaboration

Anita Rao 1 collaboration

Vinit Waichale 1 collaboration

Arnab Sinha Roy 1 collaboration

Shilpa Ramaswamy 1 collaboration

Divya Pathak 1 collaboration

Ronald R Bowsher 1 collaboration